The Maharashtra Industrial Development Corporation (MIDC) will be picking up a stake of around 11 per cent in the proposed 100 acre biotechnology park at Hinjawadi, near Pune in lieu of the land that it contributes to the project.
The project will be implemented through a special purpose vehicle, in which MIDC will pick up 11 per cent equity. The remaining 89 per cent equity will be held by a single developer or a consortium of companies. Several biotechnology, pharmaceutical, logistics and equipment companies have evinced interest in the project.
Ernst & Young and Rabo India Finance have been appointed to look for equity partners for the project.
As a majority stakeholder, the private partner would have to finalise the blueprint along with the funding strategy and the marketing plan of the park. MIDC, apart from being an equity investor, would secure partnerships with research institutions, government agencies and hospitals. It would also secure concessions from the government and assist in regulatory clearances.
